This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessReview
Staurosporine as an Antifungal Agent
by
Filipa C. Santos
Filipa C. Santos
,
Joaquim T. Marquês
Joaquim T. Marquês
,
Eva N. Santos
Eva N. Santos and
Rodrigo F. M. de Almeida
Rodrigo F. M. de Almeida *
Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(19), 9683; https://doi.org/10.3390/ijms26199683 (registering DOI)
Submission received: 25 August 2025
/
Revised: 23 September 2025
/
Accepted: 24 September 2025
/
Published: 4 October 2025
Abstract
Staurosporine (STS) was discovered in 1977 by Omura and colleagues during a chemical screening for microbial alkaloids. It was the first indolocarbazole compound isolated from a soil-dwelling bacterium, Streptomyces staurosporeus. STS was also found to have antifungal activity, but its potent protein kinase (PK) inhibitory properties, perhaps the most extensively characterized biochemical feature of STS, were only revealed nearly a decade after its discovery. Thereafter, STS has been studied mainly for its anticancer potential with foreseen applications ranging from biomedical (e.g., antiparasitic) to agricultural (e.g., insecticidal). Interestingly, the recent discovery that STS induces apoptosis in the filamentous fungus Neurospora crassa renewed interest in this molecule as a scaffold for antifungal drug development. Studies in fungi and mammalian cell lines suggest that, in addition to PK inhibition, other modes of action are possible for STS. These may involve the targeting of membrane lipid domains and/or alterations of membrane biophysical properties. Here, the studies on the action of STS and its natural and synthetic derivatives against diverse fungal species, since its discovery to the present day, are critically reviewed and discussed with the aim of highlighting their advantages, limitations to be overcome, conceivable mechanisms of action, and potential as antifungal chemotherapeutic agents.
Share and Cite
MDPI and ACS Style
Santos, F.C.; Marquês, J.T.; Santos, E.N.; de Almeida, R.F.M.
Staurosporine as an Antifungal Agent. Int. J. Mol. Sci. 2025, 26, 9683.
https://doi.org/10.3390/ijms26199683
AMA Style
Santos FC, Marquês JT, Santos EN, de Almeida RFM.
Staurosporine as an Antifungal Agent. International Journal of Molecular Sciences. 2025; 26(19):9683.
https://doi.org/10.3390/ijms26199683
Chicago/Turabian Style
Santos, Filipa C., Joaquim T. Marquês, Eva N. Santos, and Rodrigo F. M. de Almeida.
2025. "Staurosporine as an Antifungal Agent" International Journal of Molecular Sciences 26, no. 19: 9683.
https://doi.org/10.3390/ijms26199683
APA Style
Santos, F. C., Marquês, J. T., Santos, E. N., & de Almeida, R. F. M.
(2025). Staurosporine as an Antifungal Agent. International Journal of Molecular Sciences, 26(19), 9683.
https://doi.org/10.3390/ijms26199683
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.